A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Logitech K400 Plus Wireless Touch Keyboard Review
Republican congressman faces wrath of DeSantis campaign with call to ‘correct’ Black history standards
IShowSpeed accuses xQc of using N-word during 'Fortnite' livestream: 'You said it, I'm not tripping'
This is the reason why self-service checkouts are fitted with mirrors
Jigx Makes Breakthrough Mobile App Development Platform Available to Developers Worldwide
MrBeast breaks own YouTube views record by 'outperforming' 'Squid Game' video in just 24 hours
Analysis-Canadian wildfires shutter sawmills, drive up lumber prices
Pentagon to strengthen insider threat monitoring and vetting procedures following major intel leak